Suchergebnisse - "Andreani, Julien"

PubPharm (67)

21

Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs : Better knowledge for better patient management?

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2021

von Andreani, J. | Lupo, J. | Germi, R. | +5

22

In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2

enthalten in: Journal of clinical medicine | 2021

von Gendrot, M. | Jardot, P. | Delandre, O. | +9

23

The Kaumoebavirus LCC10 Genome Reveals a Unique Gene Strand Bias among "Extended Asfarviridae"

enthalten in: Viruses | 2021

von Geballa-Koukoulas, K. | Andreani, J. | La Scola, B. | +1

24

Clandestinovirus : A Giant Virus With Chromatin Proteins and a Potential to Manipulate the Cell Cycle of Its Host Vermamoeba vermiformis

enthalten in: Frontiers in microbiology | 2021

von Rolland, C. | Andreani, J. | Sahmi-Bounsiar, D. | +3

25

Morphological and Genomic Features of the New Klosneuvirinae Isolate Fadolivirus IHUMI-VV54

enthalten in: Frontiers in microbiology | 2021

von Andreani, J. | Schulz, F. | Di Pinto, F. | +3

26

Methylene blue inhibits replication of SARS-CoV-2 in vitro

enthalten in: International journal of antimicrobial agents | 2020

von Gendrot, M. | Andreani, J. | Duflot, I. | +10

27

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2

enthalten in: Molecules (Basel, Switzerland) | 2020

von Gendrot, M. | Andreani, J. | Jardot, P. | +11

28

GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition

enthalten in: bioRxiv : the preprint server for biology | 2020

von Halfon, P. | Bestion, E. | Zandi, K. | +6

UpdateIn: Viruses. 2022 Jan 12;14(1):. - PMID 35062337

29

Advantages and limits of metagenomic assembly and binning of a giant virus

enthalten in: bioRxiv.org | 2020

von Schulz, F. | Andreani, J. | Francis, R. | +4

30

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa : In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Gendrot, M. | Duflot, I. | Boxberger, M. | +10